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Abstract : The effect of Zn2+ on t-[ 3H]butylbicycloorthoben-
zoate ([3H]TBOB) binding to the GABAA receptor complex
was studied autoradiographically in rat brain . Zn2+ inhib-
ited [3H]TBOB binding in a dose-dependent manner at
physiological concentrations . Saturation analysis revealed
noncompetitive inhibition in various brain regions . The in-
hibitory effect of Zn2+ had regional heterogeneity ; regions
showing the greatest inhibition of [3H]TBOB binding were
cortical laminae I-III, most areas of hippocampus, stria-
tum, septum, and cerebellar cortex . Regions with rela-
tively less inhibition of [3H]TBOB binding included cortical
laminae V-VI, thalamus, superior colliculus, inferior collicu-
lus, and central gray matter . The effect of Zn2+ and those
of other GABA,, ligands, such as benzodiazepines, bicu-
culline, isoguvacine, and picrotoxin, on [3H]TBOB binding
seemed to be additive . Nit+ , Cd2+ , and Cue+ also inhibited
[3H]TBOB binding with a regional heterogeneity similar to
that produced by Zn2+ . These results are consistent with
Zn2+ acting at the previously detected recognition site on
the GABA,, receptor complex, distinct from the picrotoxin,
GABA, and benzodiazepine sites . The regional heteroge-
neity of the Zn2+ effect may reflect differential regional
distribution of GABAA receptor subtypes among brain re-
gions . Other divalent canons probably act at the Zn2+ bind-
ing site . Key Words : Zinc-t-Butylbicycloorthobenzoate
-GABA-GABA,, receptor complex-Autoradiography .
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The GABAA receptor is the major mediator of syn-
aptic inhibition in the CNS and structurally is a het -
erooligomeric protein comprised offive (or fewer) sub-
units per active complex (Burt and Kamatchi, 1991) .
Molecular cloning studies have provided evidence for
the existence of a number of different subunits form-
ing the GABAA receptor, and each of these subunits
has a distinct regional distribution in the brain (Olsen
and Tobin, 1990; Burt and Kamatchi, 1991 ; Lüddens
and Wisden, 1991 ; Doble and Martin, 1992; Wisden
et al ., 1992) . Functionally, the GABAA receptor incor-
porates a chloride ionophore, as well as binding sites
for several classes of ligands that interact allosterically
either to potentiate or to inhibit receptor function
(Burt and Kamatchi, 1991 ; Sieghart, 1992) .
Divalent canons have been shown to modulate
GABAA receptors in biochemical and electrophysio-
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logical studies . Zn2+ and other metal canons, includ-
ing Cd2+ , Nit+ , Mn2+ , and Cot+ , inhibited the GABA
response of neurons in a variety of preparations
(Smart and Constanti, 1982; Kaneko and Tachibana,
1986; Celentano et al ., 1991 ; Smart, 1992 ; Kilié et al.,
1993) . Binding studies have provided evidence for
Zn2+ modulation of GABA ligand binding . Zn2+ en-
hanced the specific binding of [ 3H]diazepam in the
CNS (MacKerer and Kochman, 1978) . Although
Zn2+ seemed to increase [ 3H]GABA binding to synap-
tic membranes at physiological concentrations, it in-
hibited the binding at pharmacotoxicological doses
(Baraldi et al ., 1984) . An autoradiographic study
showed that Zn2+ inhibited [3H]GABA binding to
GABAB receptors, but not significantly to GABAA re-
ceptors in any brain region (Turgeon and Albin,
1992) . For the picrotoxin binding site, a binding site
on the GABA,, receptor complex whose binding is
modulated by the activation of other ligand binding
sites of the GABAA receptor complex, there are no
published data on the effect of Zn2+ and other diva-
lent canons .
The effects of drugs on picrotoxin ligand binding
have been used frequently to assess ligand interac-
tions with the GABAA receptor complex . The pur-
poses of this study were to elucidate Zn2+ effects on
picrotoxin ligand binding, to examine the regional het-
erogeneity of the Zn2+ effect on GABAA receptors,
and to study the possible interaction of Zn2+ effects
with the effects of other classes of GABAA receptor
ligands . The picrotoxin binding site of the GABAA
receptor complex can be assayed with t-[3H]-
butylbicycloorthobenzoate ([ 3H]TBOB) (Lawrence et
al ., 1985 ; O'Connor and McEwen, 1986; Sakurai et
al ., 1992) . We used in vitro quantitative autoradiogra-
phy to determine the effects of Zn2+ on [ 3H]TBOB
binding in rat brain .
Received May 20, 1993 ; revised manuscript received June 30,
1993 ; accepted July 8, 1993 .
Address correspondence to Dr. R. L. Albin at Department of
Neurology, University of Michigan, Neuroscience Laboratory
Building, 1103 E. Huron, Ann Arbor, MI 48104, U.S.A .
Abbreviations used. TBOB, t-butylbicycloorthobenzoate; TBPS,
t-butylbicyclophosphorothionate.
EXPERIMENTAL PROCEDURES
Male Sprague-Dawley rats (175-199 g ; Harlan Labs, In-
dianapolis, IN, U.S.A .), were decapitated, and their brains
rapidly removed and frozen in Lipshaw embedding matrix
surrounded by powdered dry ice . Twenty-micrometer-thick
sections were cut horizontally on a Lipshaw cryostat . Sec-
tions were obtained at the level including the caudoputa-
men, thaw-mounted onto 2 X subbed gelatin-coated slides
on a warming plate, and stored at -20°C until the time of
assay . All assays were performed 24 h after decapitation .
Sections were run in triplicate. Slide-mounted tissue sec-
tions were warmed to room temperature and prewashed for
3 X 10 min in buffer (50 mM Tris-HCl plus 1 mM EDTA,
pH 7 .4 at 4°C) at 4°C and dried under a stream ofcool air .
Binding of [ 3H]TBOB (20 nM) was carried out in buffer (50
mMTris-HCl plus 120 mMNaCI, pH 7 .4, at room tempera-
ture) for 90 min at room temperature . The incubation was
terminated by two 30-min rinses in buffer (50 mM Tris-
HCI, pH 7.4, at 4°C) at 4°C, followed by a brief dip in
distilled water. Each slide was then dried under a stream of
hot air. Nonspecific binding was assessed in the presence of
20 ~M picrotoxin . For analysis of the Zn2+ effect on ['H]-
TBOB binding, tissue sections were incubated with nine
concentrations of ZnCl2 ranging from 1 nM to 1 mM with
20 nM [ 3H]TBOB . Saturation studies were performed with
nine concentrations of ['H]TBOB ranging from 1 pM to
100 nM. Specific [ 3H]TBOB binding and nonspecific bind-
ing were determined at all concentrations of [ 3H]TBOB in
both the presence and the absence of 100 ~M ZnCl2 . To
determine the interaction of Zn2+ effects with the effects of
other GABAA ligands that modulate [ 3H]TBOB binding,
other GABAA ligands were included in the incubation mix-
ture with 20 nM [3H]TBOB in both the presence and ab-
sence of 100 wM ZnCl2 . The effects ofother divalent canons
on [3H]TBOB binding were analyzed in the incubation mix-
ture with 20 nM [ 3H]TBOB . Autoradiograms were gener-
ated by apposing the slides to 3H-sensitive film (Hyperfilm,
Amersham Inc ., Arlington Heights, IL, U.S.A .) in light-
tight cassettes along with standards containing known
amounts of radioactivity . After 3 weeks, films were devel-
oped in Kodak D-19 . Ligand binding was quantitated with
computer-assisted densitometry using the MCID system
(Imaging Research Inc., St. Catharines, Ontario, Canada) .
To quantify ligand binding density, the optical density of
coexposed standards was determined and a standard curve
generated by fitting standard values with a fourth-degree
polynomial regression equation . Standards were commer-
cial' °C plastic standards (ARC, St . Louis, MO, U.S.A .) . Use
of the standards and derived standard curve allow conver-
sion of areal optical density to picomoles per milligram of
protein . Areas read included the cortical laminae I-III, lam-
ina IV, and laminae V-VI, hippocampal CA 1 stratum or-
iens, CA 1 stratum radiatum, CA3 stratum oriens, CA3 stra-
tum radiatum, and dentate gyrus, striatum, thalamus (later-
odorsal thalamic nucleus and lateral posterior thalamic
nucleus), septum, superior colliculus, inferior colliculus,
periaqueductal gray matter, and cerebellar molecular and
granule cell layers . Ten to 20 readings per area from tripli-
cate sections were averaged . IC SO values for Zn2+ were calcu-
lated by log-logit analysis . In the saturation experiment, val-
ues of specific [ 3H]TBOB bound were quantified to con-
struct Scatchard plots .
Materials
[3H]TBOB (sp . act . 19 .4 Ci/mmol) was purchased from
Amersham . Clonazepam was the gift of Dr . Peter Sorter
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FIG . 1 . Curves for the inhibition of [ 3H]TBOB binding by Znz~ in
laminae I-III, lamina IV, and laminae V-VI of the cerebral cortex .
Zn2+ inhibited TBOB binding in a dose-dependent manner . Data
are means ± SEM (bars) from experiments carried out with three
animals .
(Hoffmann-La Roche) . Zolpidem was the gift of Synthe-
labo Recherche . Isoguvacine was purchased from Cam-
bridge Research Biochemicals Ltd . (Cambridge, U.K.). Bi-
cuculline and picrotoxin were purchased from Research Bio-
chemicals Inc . (Natick, MA, U.S.A .) . The remaining
reagents were purchased from Sigma Chemical (St. Louis,
MO, U.S.A .) and were of the highest possible purity .
RESULTS
ZnZ+ modulation of [3H]TBOB binding
ZnZ+ produced dose-dependent inhibition of [3H]-
TBOB binding in rat brain sections (Fig . 1) . Inhibi-
tion of [ 3H]TBOB binding was observed in all areas
examined (Fig . 2 and Table 1). Saturation analysis of
[ 3H]TBOB in the presence of 100 ~M Zn2+ revealed a
significant decrease in Br aX with little change in KD in
most regions (Table 2) .
Regional difference of ZnZ+ modulation of [3H]TBOB
binding
The observed regional distribution of [ 3H]TBOB
binding sites was similar to that reported previously
by Olsen et al. (1990) . Picrotoxin displaced to the
same extent all the [ 3H]TBOB bound in all brain re-
gions (data not shown). On the other hand, there were
regional differences in ZnZ+ inhibition of [3H]TBOB
binding (Fig. 1). ICSO values for Zn2+ were signifi-
cantly different among brain regions (p < 0.05 on
ANOVA; Table 1), with ICSO values lowest in cortical
laminae I-III, the cerebellar molecular layer, and sep-
tum . Relatively low ICso values were observed also in
most subfields of the hippocampus, the striatum, and
cerebellar granule cell layer . Relatively high ICSO val-
ues were found in cortical laminae V-VI, thalamus,
superior colliculus, inferior colliculus, and periaque-
ductal gray matter .
Pharmacological profile of [ 3H]TBOB binding
Compounds that modulate the activity of the GA-
BAA receptor complex allosterically modulate bind-
J. Neurochem., Vol. 62, Na 2, 1994
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FIG. 2. Autoradiographs of [3H]TBOB binding in the absence (-Zn) and presence (+Zn) of 100 ~M Zn2+ in horizontal sections of rat brain .
Zn2+ inhibited [3H]TBOB binding in all areas with regional heterogeneity . Regions showing the greatest inhibition of [3H]TBOB binding were
cortical laminae I-III, most areas of hippocampus, striatum, septum, and cerebellar cortex . Regions with relatively less inhibition of
[3H]TBOB binding included cortical laminae V-VI, thalamus, superior colliculus, inferior colliculus, and periaqueductal gray matter. I-III,
cortical laminae I-III ; IV, cortical lamina IV ; V-VI, cortical laminae V-VI ; CA1, CA1 stratum oriens ; CA3, CA3 stratum oriens ; DG, dentate
gyrus; Gr, cerebellar granule cell layer; IC, inferior colliculus ; Mol, cerebellar molecular layer; PAG, periaqueductal gray matter ; SC,
superior colliculus ; Str, striatum ; Thal, thalamus .
ing of the picrotoxin ligands, t-[35S]butylbicyclophos-
phorothionate ([35S]TBPS) and [3H]TBOB. The ben-
zodiazepine agonists, clonazepam and zolpidem, en-
hance TBPS and TBOB binding at concentrations
between 100 nM and 1 ~M (Lloyd et al ., 1990 ; Sa-
kurai et al ., 1992 ; Kume et al ., unpublished observa-
tions) . GABAA agonists, such as muscimol and isogu-
vacine, inhibit TBPS and TBOB binding (Squires et
al ., 1983 ; Lawrence et al ., 1985 ; Edgar and Schwanz,
1990 ; Sakurai et al ., 1992), whereas the GABAA com-
petitive antagonist bicuculline enhances their binding
in the cerebellar granule cell layer (Squires et al .,
1983 ; Korpi et al ., 1992 ; Sakurai et al ., 1992). In this
experiment, Zn2+ inhibited [3H]TBOB binding in the
presence ofeither clonazepam or zolpidem (Fig . 3) . In
the presence ofeither isoguvacine or bicuculline, Zn2+
produced approximately the same percent reduction
of TBOB binding as that produced in the absence of
thesecompounds. The effects ofZn2+ and benzodiaze-
pines, isoguvacine, and bicuculline seemed to be es-
sentially additive. Picrotoxin is considered to be a
competitive inhibitor of [3H]TBOB (Lawrence et al .,
1985). The inhibition by picrotoxin and Zn2+ also
seemed to be additive (Fig . 3) .
Modulation of [3H]TBOB binding by other divalent
canons
Nit+, Cd2+, andCue+ at 300 wMalso inhibited [3H]-
TBOB binding (Fig . 4) . There were regional differ-
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ences in the inhibition of [3H]TBOB binding similar
to that produced by Zn2+ .
DISCUSSION
The primary finding of this study is that Zn2+ pro-
duced dose-dependent inhibition of [3H]TBOB bind-
ing in rat brain sections . Zn2+ inhibition of[3H]TBOB
binding was observed in all areas examined, and there
were regional differences in the Zn2+ effect on ['H]-
TBOB binding. Saturation analysis indicated that
Zn2+ inhibits [3H]TBOB binding in a noncompetitive
manner . Divalent canons are known to form soluble
complexes with some ligands (Crawford and McBur-
ney, 1977) . IfZn2+ formsasoluble complex with [3H]-
TBOB, reducing the concentration offree [3H]TBOB,
Zn2+ would decrease the amount of free [3H]TBOB
interacting with the GABAA receptor. In this case,
however, an autoradiogram obtained from the incu-
bation mixture of [3H]TBOB with Zn2+ would show
uniform decrease in regional binding and not the re-
gional differences we documented . Moreover, soluble
complex formation should not alter theBmaX ofsatura-
tion curves . Our results indicate a noncompetitive in-
teraction, and these observations cannot be explained
by the hypothesis of complex formation. We infer
that Zn2+ is acting as an inhibitor of [3H]TBOB bind-
ing by acting at a site on the GABAA receptor .
TABLE 1. Inhibition of(3HJTBOB binding in various
brain regions by ZnZ+
IC so values were derived from inhibition curves with ZnCIZ . Data
are means ± SEM from experiments with three animals . A signifi-
cant difference of the ICso values among regions was noted using
one-way ANOVA (p < 0.05) .
Our results are consistent with prior electrophysio-
logic data and indicate that our binding data address
the same phenomena described in electrophysiologic
studies . Our observed IC So values approximate 100
wM, which is consistent with results obtained in sev-
eral functional studies (Smart and Constanti, 1982;
Westbrook and Mayer, 1987; Celentano et al ., 1991 ;
Legendre and Westbrook, 1991 ; Smart et al ., 1991 ;
Smart, 1992 ; Kilié et al ., 1993), andthe effects ofZnZ+
are mimicked by other divalent metal canons, a phe-
nomenon noted also in electrophysiologic studies
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(Kaneko and Tachibana, 1986; Celentano et al .,
1991).
ZnZ+ is present in many synaptic vesicles in the ver-
tebrate CNS(Pérez-Clausell and Danscher, 1985) and
is released into the extracellular space during neuro-
nal activity (Assaf and Chung, 1984 ; Howell et al .,
1984). Assafand Chung (1984) demonstrated extra-
cellular concentrations of ZnZ+ as high as 300 ~Mfol-
lowing depolarization . The effective concentration
range for ZnZ+ effects in our study and prior electro-
physiologic studies (Smart and Constanti, 1982 ;
Westbrook and Mayer, 1987 ; Celentano et al ., 1991 ;
Legendre and Westbrook, 1991 ; Smart et al ., 1991 ;
Smart, 1992 ; Kilié et al ., 1993) is within the probable
physiological concentration range of ZnZ+ within the
synaptic cleft . ZnZ+ may function as an endogenous
neuromodulator of GABAA receptor complex func-
tion within the CNS.
Ourbinding data provide evidence for regional dif-
ferences in the ZnZ+ effect on the GABAA receptor
complex. Regions showing the greatest inhibition of
[3H]TBOB binding were cortical laminae I-III, most
areas of hippocampus, striatum, septum, and cerebel-
lar cortex . Regions with relatively less inhibition of
[3H]TBOB binding included cortical laminae V-VI,
thalamus, superior colliculus, inferior colliculus, and
periaqueductal gray matter.
The pharmacological and molecular biological evi-
dence for regional heterogeneity oftheGABAA recep-
tor complex has been widely reported, and regional/
cellular differences in the expression of GABAA re-
ceptor subtypes probably underlie, at least in part,
regional/cellular differences in receptor function and
pharmacology (Olsen and Tobin, 1990 ; Burt and Ka-
matchi, 1991). Recent recombinant receptor studies
have shown that GABAA receptors expressing the ^y2
subunit are relatively insensitive to ZnZ+ (Draguhn et
al ., 1990 ; Smart et al ., 1991), suggesting that the pres-
ence of y2 subunits is an important determinant of
the relative ZnZ+ sensitivity of native GABAA recep-
tors . It is likely that each brain region expresses a vari-
ety of GABAA receptors of varying isoform composi-
tion with substantial regional differences in the ex-
pressed amount of different types of receptor
heterooligomers. The 'y2 subunit is expressed in vir-
TABLE 2. Saturation bindingparameters of(3HJTBOB binding
in several brain regions
KD (nM) and Bmax (pmol/mg ofprotein) values were determined in the presence and absence of
100 uMZnCIZ . Data are means ± SEM from experiments with three animals .
° A significant difference between -Zn and +Zn was noted using two-tailed t test (p < 0.05) .
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Brain region ICso (~M)
With high effect of Zn Z + :
Neocortex
Laminae I-III 42 .2 ± 4 .1
Hippocampus
CA I stratum oriens 74 .8 ± 5 .3
CA 1 stratum radiatum 57 .0 ± 16 .3
CA3 stratum oriens 46 .9 ± 2.8
Dentate gyrus 59 .4 ± 4 .5
Striatum 83 .5 ± 15 .7
Septum 48 .3 ± 8 .1
Cerebellum
Molecular layer 47 .7 ± 8 .8
Granule cell layer 70 .8 ± 27.6
With moderate effect ofZnZ+ :
Neocortex
Lamina IV 102 .5 ± 16 .8
Hippocampus
CA3 stratum radiatum 113 .3 ± 10 .8
Pre-/parasubiculum 123 .6 ± 17 .5
With low effect of Zn Z + :
Neocortex
Laminae V-VI 150,6 ± 9.4
Thalamus 167 .2 ± 14 .8
Superior colliculus 214 .2 ± 4 .7
Inferior colliculus 247 .9 ± 43 .3
Central gray mater 193,6 ± 12 .8
Brain region KD (-Zn) KD (+Zn) B~,~ (-Zn) Bm,x (+Zn)
Cerebral cortex
Laminae I-III 24.0 ± 1 .5 37 .0 ± 2 .4° 2 .25 ± 0.21 0 .61 ± 0.07°
Lamina IV 22 .7 ± 2 .2 28.7±0.6 2.84±0.30 1 .46±0.16°
Laminae V-VI 30 .3 ± 3 .6 34.2±5.3 2.60±0.27 1 .92±0.11
Striatum 55 .7 ± 11 .1 35.7±5.6 1 .80±0.26 0.74±0.13°
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FIG . 3 . Zn 2+ effects were essentially additive to those of other
GABAA ligands . The graphs show the results in the cortical lami-
nae V-VI (a) and in the cerebellar granule cell layer (b) . The experi-
ment was performed in the presence of 500 nM clonazepam
(Clo), 500 nM zolpidem (Zol), 10 ~M isoguvacine (Iso), 600 nM
picrotoxin (Pic), or 100 ~M bicuculline (Bic), each done in the ab-
sence and presence of 100 ~aM Zn2+ . Zn 2' produced inhibition in
the presence of either clonazepam or zolpidem (a) . Zn2 added
another inhibitory effect to the inhibition produced by either isogu-
vacine or picrotoxin . Zn 2 decreased the enhancement of [3H]-
TBOB binding by bicuculline in the cerebellar granule cell layer (b) .
Data are means ± SEM (bars) from experiments with three ani-
mals .
tually all brain regions examined (Wisden et al .,
1992), albeit at low levels in many regions, and it is
likely that most, if not all, brain regions possess y2-
containing GABAA receptors . Recombinant recep-
tors without y2 subunits [a1ß1 (Draguhn et al .,
1990), a1ß2 (Smart et al ., 1991)] have ICso values for
Znz+ approximating 1 ~M. These ICSO values are
much lower than those of either recombinant recep-
tors containing ~y2 subunits or native GABAA recep-
tors, and are significantly lower than the ICSO values of
the Znz+ effect on [ 3H]TBOB binding . It is likely that
the presence of GABAA receptors containing y2 sub-
units accounts for the relative insensitivity of native
receptors compared with recombinant receptors lack-
ing y2 receptors .
Our autoradiographic binding data, however, sug-
gest that the relative abundance of y2 subunits is not
the sole determinant of regional differences in the
Znz+ sensitivity of GABAA receptors . The neocortex,
hippocampus, and cerebellar cortex are brain regions
J. Neurochem., Vol. 62, No . 2, 1994
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in which abundant y2 mRNA has been detected, and
the 'y2 subunit is considered to be a primary compo-
nent of native GABAA receptor complexes (Laurie et
al ., 1992 ; Wisden et al ., 1992) . Therefore, those re-
gions are predicted to be less sensitive to Znz+ . In our
autoradiograms, however, those brain regions showed
relatively high sensitivity to the effects ofZnz+ . More-
over, our data show that thalamus, which contains a
relatively low level of ~y2 subunit mRNA (Wisden et
al ., 1992), was relatively insensitive to Znz+ . These
results are consistent with the suggestion of Smart et
al . (1991) that some combinations of GABAA recep-
tor subunits that lack the y2 subunit are also likely to
be insensitive to Znz+. Comparison of our data with
the reported distribution of other GABAA receptor
subunit mRNAs (Laurie et al ., 1992 : Wisden et al.,
1992) reveals that the distribution ofno single subunit
correlates with the distribution of the Znz+ effect on
[ 3H]TBOB binding . The degree of susceptibility to the
effects ofZnz+ may be regulated by complex combina-
tionsofsubunitsand/orby posttranslational modifica-
tion of GABAA receptor complexes .
Electrophysiologic studies (Smart and Constanti,
1982 ; Celentano et al ., 1991 ; Smart, l 992) indicate
that modulation of GABAA receptor function by ben-
zodiazepines, barbiturates, neurosteroids, bicucul-
line, and picrotoxin does not interfere with the antago-
nism exerted by Znz+ . These studies suggest the exis-
tence of a Znz+ site distinct from other modulatorv
GABAA ligand binding sites . Our binding data are
consistent with this inference . The effect of Znz+ and
those of other GABAA ligands on [ 3H]TBOB binding
seemed to be additive, a result consistent with the ex-
istence of a separate Znz+ site . There is a possible dis-
crepancy between our results and prior electrophysio-
logic data (Celentano et al ., 1991 ; Smart, 1992) . Our
results indicate that Znz+ inhibits picrotoxin ligand
binding, and this suggests that Znz+ might decrease
the effectiveness ofpicrotoxin, a result not apparently
FIG . 4. Divalent metal cations inhibit [3H]TBOB binding with simi-
lar regional differences in effect . [3H]TBOB binding was more in-
hibited in laminae I-III than in laminae IV and V-VI of the cerebral
cortex . Data are means ± SEM (bars) from experiments done
with three animals . 'A significant difference from laminae I-III and
IV was noted using ANOVA (P < 0.05) .
seen in prior studies . Zn2+, however, is a noncompeti-
tive inhibitor of [ 3H]TBOB binding with a predomi-
nant effect on Bmax and little effect on binding site
affinity . Prior studies of Zn2+-picrotoxin interactions
were done with single, subsaturating concentrations
of picrotoxin, and full dose-response curves achiev-
ing saturating concentrations of picrotoxin might be
necessary to document a Zn2+-picrotoxin interac-
tÍOn .
In addition to Zn2+ , other divalent metal canons,
such as Cot+ , Ni2+ , Mn2+ , and Cd2+ , also have been
reported to inhibit GABA-induced current noncom-
petitively (Kaneko and Tachibana, 1986; Celentano
et al ., 1991) . These canons probably act at a common
site, but possess different intrinsic efficacies as allos-
teric inhibitors, such that Zn2+ has greater efficacy
than Cd2+ (Celentano et al ., 1991) . In the present
study, 300 ~M Ni2+, Cd2 , and Cue+ inhibited [ 3H]-
TBOB binding as well as 300 ~M Zn2+ . Moreover,
there were regional differences in the inhibition of
['H]TBOB binding, similar to that produced by Zn2+ .
These results suggest that Ni2+ , Cd2+ , and Cue+ act at
the Zn2+ binding site .
Further studies will be necessary to establish the
subunit composition, location, and functional proper-
ties of cation-sensitive GABAA receptor subtypes .
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